Sunitinib in Treating Patients With Advanced Malignant Pleural Mesothelioma - Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00392444

Locations


Canada
	L'Hopital Laval	Recruiting
	Quebec, Canada, G1V 4G5
	Contact: Francis Laberge 418-656-4747

Canada, Alberta
	Cross Cancer Institute at University of Alberta	Recruiting
	Edmonton, Alberta, Canada, T6G 1Z2
	Contact: Quincy Chu 780-432-8248

Canada, British Columbia
	BCCA - Fraser Valley Cancer Centre	Recruiting
	Surrey, British Columbia, Canada, V3V 1Z2
	Contact: Christopher Lee 604-930-4017
	British Columbia Cancer Agency - Centre for the Southern Interior	Recruiting
	Kelowna, British Columbia, Canada, V1Y 5L3
	Contact: Delia Sauciuc 250-712-3900
	British Columbia Cancer Agency - Vancouver Cancer Centre	Recruiting
	Vancouver, British Columbia, Canada, V5Z 4E6
	Contact: Nevin Murray 604-877-6000

Canada, Nova Scotia
	Nova Scotia Cancer Centre	Recruiting
	Halifax, Nova Scotia, Canada, B3H 1V7
	Contact: Wojciech Morzycki 902-473-8317

Canada, Ontario
	Margaret and Charles Juravinski Cancer Centre	Recruiting
	Hamilton, Ontario, Canada, L8V 5C2
	Contact: John Goffin 905-387-9495
	Ottawa Hospital Regional Cancer Centre - General Campus	Recruiting
	Ottawa, Ontario, Canada, K1H 8L6
	Contact: Scott Laurie 613-737-7700
	Princess Margaret Hospital	Recruiting
	Toronto, Ontario, Canada, M5G 2M9
	Contact: Ronald Feld 416-946-2260

Sponsors and Collaborators

National Cancer Institute of Canada

National Cancer Institute (NCI)

Investigators


Study Chair:	Scott A. Laurie, MD, FRCPC	Ottawa Hospital Regional Cancer Centre - General Campus